SIRT1 deficiency interferes with membrane resealing after cell membrane injury

PLoS One. 2019 Jun 26;14(6):e0218329. doi: 10.1371/journal.pone.0218329. eCollection 2019.

Abstract

Activation of SIRT1, an NAD+-dependent protein deacetylase, ameliorates muscular pathophysiology of δ-sarcoglycan-deficient TO-2 hamsters and dystrophin-deficient mdx mice. We found that SIRT1 was highly expressed beneath the cellular membranes of muscle cells. To elucidate functional roles of SIRT1 on muscles, skeletal muscle-specific SIRT1 knockout mice (SIRT1-MKO) were generated. SIRT1-MKO mice showed muscular pathology similar to mild muscular dystrophies with increased numbers of centrally nucleated small myofibers and decreased numbers of middle-sized (2000-3001 μm2) myofibers compared to those of wild-type (WT) mice. Accordingly, SIRT1-MKO mice showed significantly decreased exercise capacity in treadmill and inverted hanging tests with higher levels of serum creatine kinase activities compared with those in WT mice. Evans blue dye uptake after exercise was greater in the muscles of SIRT1-MKO than those of WT mice, suggesting membrane fragility in SIRT1-MKO mice. Because SIRT1 was dominantly localized beneath the membranes of muscular cells, SIRT1 may have a new role in the membranes. We found that levels of fluorescent FM1-43 dye intake after laser-induced membrane disruption in C2C12 cells were significantly increased by SIRT1 inhibitors or Sirt1-siRNA compared with those of control cells. Inhibition of SIRT1 or SIRT1-knockdown severely disturbed the dynamic aggregation of membrane vesicles under the injured site but did not affect expression levels of membrane repair proteins. These data suggested that SIRT1 had a critical role in the resealing of membrane-ruptured muscle cells, which could affect phenotypes of SIRT1-MKO mice. To our knowledge, this report is the first to demonstrate that SIRT1 affected plasma-membrane repair mechanisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Membrane / metabolism
  • Mice
  • Mice, Knockout
  • Muscle, Skeletal / physiopathology
  • Muscular Dystrophy, Animal / genetics
  • Muscular Dystrophy, Animal / physiopathology
  • Physical Conditioning, Animal
  • Sirtuin 1 / genetics*

Substances

  • Sirt1 protein, mouse
  • Sirtuin 1

Grants and funding

This study was supported in part by the Japanese Society for the Promotion of Science (JSPS) KAKENHI Grant (https://kaken.nii.ac.jp/ja/index/) Numbers 15K08312 (YH), 17K08600 (AK), 17K15582 (RH), 18K06965 (YH) and JP16H06280 (YH) (Grant-in-Aid for Scientific Research on Innovative Areas – Platforms for Advanced Technologies and Research Resources “Advanced Bioimaging Support”) (http://www.nibb.ac.jp/abis/acknowledgements); and grants from the Setsuro Fujii Memorial, the Osaka Foundation for Promotion of Fundamental Medical Research (YH) (https://www.weblio.jp/content/%E4%B8%80%E8%88%AC%E8%B2%A1%E5%9B%A3%E6%B3%95%E4%BA%BA%E8%97%A4%E4%BA%95%E7%AF%80%E9%83%8E%E8%A8%98%E5%BF%B5%E5%A4%A7%E9%98%AA%E5%9F%BA%E7%A4%8E%E5%8C%BB%E5%AD%A6%E7%A0%94%E7%A9%B6%E5%A5%A8%E5%8A%B1%E4%BC%9A), the Osaka Medical Research Foundation for Intractable Diseases (RH, NI) (http://www.nanbyo.or.jp/), the Japan Research Foundation for Clinical Pharmacology (AK) (https://www.rinyaku-fdn.or.jp/), and MSD Life Science Foundation, Public Interest Incorporates Foundation (AK, NI) (https://www.msd-life-science-foundation.or.jp/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.